Machine Learning: A new approach to drug discovery

Fields Institute · Mar 22, 2021
Daphne Koller, CEO & Founder of insitro, discusses developing a new approach to drug development that uses high-quality data and ML models to design novel, safe, and effective therapies that help more people, faster, and at a lower cost.